Literature DB >> 2637679

Pharmacokinetics of morphine following administration by the buccal route.

A R Manara1, M P Shelly, K G Quinn, G R Park.   

Abstract

The pharmacokinetics of morphine administered via the buccal route as a controlled release formulation were assessed after the administration of three different doses and found to be linear in the dose range 10-30 mg. The plasma concentrations of morphine-3-glucuronide and morphine-6-glucuronide demonstrated considerable inter-subject variation and conclusions could not be drawn regarding their pharmacokinetics. These large differences may reflect not only variability in buccal absorption, but may have resulted from the preparation dissolving in saliva, followed by absorption from the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2637679     DOI: 10.1093/bja/62.5.498

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Failure of itraconazole to prevent Enterocytozoon bieneusi infection.

Authors:  H Albrecht; H J Stellbrink; I Sobottka
Journal:  Genitourin Med       Date:  1995-10

2.  Formulation and in vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets.

Authors:  S Anlar; Y Capan; O Güven; A Göğüş; T Dalkara; A A Hincal
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

3.  Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.

Authors:  Renée McCulloch; Mohammed Sattar; Ellen M Henderson; Majella E Lane; Myra Bluebond-Langner
Journal:  Palliat Med       Date:  2017-06-20       Impact factor: 4.762

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.